Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,793 | 9,806 | 18,350 | 5,158 | 42 |
| Marketable Securities | 42 | 3,934 | 1,781 | N/A | N/A |
| Receivables | 45 | 65 | 41 | 45 | 66 |
| TOTAL | $6,299 | $14,129 | $20,327 | $5,340 | $145 |
| Non-Current Assets | |||||
| PPE Net | 403 | 43 | 42 | 21 | 4 |
| Intangibles | 799 | 902 | 968 | 1,049 | 1,068 |
| TOTAL | $1,202 | $945 | $1,011 | $1,070 | $1,072 |
| Total Assets | $7,500 | $15,074 | $21,338 | $6,410 | $1,217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | 1,190 | 713 | 284 | 237 |
| TOTAL | $1,673 | $1,190 | $713 | $284 | $456 |
| Non-Current Liabilities | |||||
| TOTAL | $247 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,920 | $1,190 | $713 | $284 | $456 |
| Shareholders' Equity | |||||
| Common Shares | 50,212 | 52,239 | 51,748 | 33,181 | 25,304 |
| Retained earnings | -55,958 | -49,185 | -39,017 | -32,904 | -29,619 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 102 |
| TOTAL | $5,580 | $13,883 | $20,625 | $6,125 | $761 |
| Total Liabilities And Equity | $7,500 | $15,074 | $21,338 | $6,410 | $1,217 |